|
Gelfoam Injection for Vocal Cord
Paralysis and Glottic Incompetence
I. GENERAL CONSIDERATIONS
A. Indications
1. Symptomatic glottic insufficiency
a. Laryngeal paralysis or laryngeal
paresis in patient whose recovery of vocal cord
mobility is uncertain
b. Glottic insufficiency with mobile vocal folds
(ie, presbylaryngis)
2. Symptoms: dysphonia, dysphagia, poor cough
B. Contraindications
1. Inability to perform direct laryngoscopy
a. Unstable cervical spine
b. Unable to obtain exposure of the larynx (ie,
retrognathic)
2. May consider other approaches
a. Percutaneous injection through
cricothyroid membrane (see Laryngeal
fat injection protocol)
b. Transoral injection employing indirect mirror
exposure of larynx
II. PREOPERATIVE PREPARATION
A. Evaluation
1. Essential for most cases
a. Speech pathology assessment (see
Laryngeal diagnostics protocol)
b. Videolaryngoscopy with voice recording (see
Videostroboscopy
protocol)
2. Consider for selected cases
a. Trial of voice therapy
b. Laryngeal electromyography (see Laryngeal
EMG protocol)
3. With history of neck arthritis or neck
surgery/injury, lateral neck radiographs inflexion and
extension
4. Offer to most patients with dentition dental
prosthetics evaluation preoperatively to fashion a
tailored (custom-made) acrylic dental splint
a. To prevent dental injury more
effectively than can the standard plastic
gump
b. To patients with difficult exposure in whom
the acrylic guard will permit a greater degree of
force applied to dentition through fulcrum
laryngoscopy (see suggested reading Dental
Protection During Rigid Endoscopy)
B. Consent
1. Describe procedure and expected recovery
a. Identify that the Gelfoam provides
temporary (2 months) medialization for most
b. Identify that voice quality will evolve after
Gelfoam placement
2. Potential complications
a. Bleeding, infection, reaction to
anesthetic
b. Damage to adjacent structures
(1) Lips, teeth, tongue, larynx from
direct laryngoscopy
(2) Hoarseness, airway obstruction, continued
dysphagia with aspiration
III. NURSING CONSIDERATIONS
A. Room Setup
1. See Endoscopy
Room Setup
a. Iowa modified suspension
b. Audio-visual unit
c. Microscope with a 400 lens
B. Instrumentation and Equipment
1. Standard
a. Arnold
Bruening intraoral injection tray
b. Direct
laryngoscope tray
2. Special
a. Bronchoscopy
tray, adult
b. Freche monopolar
instrument tray
c. Laryngoscope
instrument tray, microscopic direct
d. Lewy laryngoscope
holder tray
e. Ossof-Karlin
laryngoscope instrument tray
f. Tracheotomy
tray
g. Neurosurgical cottonoids, 1/2 in x 1/2 in
h. Storz fiber optic light cable
i. Storz telescope, straight forward 0°, 5
mm x 6 7/8 in
C. Medications (specific to nursing)
1. Gelfoam powder, 1 g
2. Sodium chloride, 0.9%, preservative-free, 10 cc
(use 4 cc to mix with Gelfoam)
3. 2% lidocaine
D. Prep and Drape
1. No prep
2. Drape
a. Head drape
b. Split sheet
E. Drains and Dressings
None
F. Special Considerations
1. Instrumentation should be set up prior to
induction
2. Tracheotomy tray
and supplies should be available for an emergency
tracheotomy
3. Bruening syringe with 22-gauge needle (with a
backup syringe in case of malfunction)
4. Mix the Gelfoam powder (1 gm) with 4 cc of
sterile saline in a sterile specimen container
5. 2% lidocaine in syringe with 25-gauge needle to
apply to topically laryngeal surface through
laryngoscope after Gelfoam injection to reduce chance
of laryngospasm
IV. ANESTHETIC CONSIDERATIONS
A. General Anesthesia
1. Communication with anesthesia staff
essential
a. Oral endotracheal intubation with small
(5.5 to 6.0) endotracheal tube (MLT tube =
microlaryngeal/tracheal tube)
b. Short-term paralysis (estimate 5-minute
case)
c. Consideration for alternative methods
(1) Jet anesthesia
(2) Apnea
(3) Local anesthesia with sedation (see
Local anesthesia for
rigid endoscopy protocol)
B. Preoperative Systemic Medications
1. Glycopyrrolate 0.1 to 0.2 mg IM on call to
operating room
a. The drying effect improves exposure;
consider avoiding in patients with xerostomia
b. Vagolytic effect
2. Consider Decadron 8 to 10 mg IV when IV started
to diminish edema. Contraindications: diabetes, ulcer
disease, other
3. Antistaphylococcal antibiotics preoperatively
and for 5 days postoperatively
C. Positioning
1. May be done with head toward anesthesia or
rotated 90°
2. Head of bed elevated 15° to 30°, neck
extended with shoulder roll
V. OPERATIVE PROCEDURE
A. Expose larynx, usually with Dedo
laryngoscope.
B. Do not use microscope (it gets in the way).
1. Consider using rigid telescope connected
to video equipment to photograph vocal folds; this
exposure permits the injection to be done with full
imaging (best for teaching purposes).
2. Alternatively, inject through laryngoscope under
direct vision.
C. Employ 22-gauge needle without guard (although
guarded tip helps to prevent excessively deep injection
into the subglottis, it also precludes full view of the
needle tip as it is inserted).
D. Expose vocal folds with tip of laryngoscope at
least 3 mm above the anterior commissure to avoid
distorting glottis.
E. Load Gelfoam into a Luer Lock syringe, rotate end
of syringe containin lfoam onto the proximal end of the
Bruening syringe barrel to fill with Gelfoam and assemble
Bruening syringe.
F. Injection
1. First injection
a. Midway between tip of vocal process and
anterior commissure at the point of maximum
concavity as determined by preoperative and
intraoperative assessment
b. Use lateral aspect of needle to push false
cord laterally and inject deeply into the
paraglottic space medial to ventricle
2. Second injection
a. Immediately lateral to vocal process of
arytenoid
b. Designed to rotate vocal process medially,
not always successful
3. Employing large upbiting forceps with the tips
closed. Manipulate bolus of Gelfoam in the vocal fold
from dorsal direct and medial direction to provide
smooth contour to vocal fold
G. Spray the vocal folds and supraglottis with 2 to 4
cc of 2% lidocaine.
VI. POSTOPERATIVE CARE
A. Procedure is usually done as outpatient
1. If there is any question about adequacy of
the airway, plan overnight observation in hospital.
2. Consider evaluating larynx with indirect mirror
examination or flexible fiber optic laryngoscope
before discharge.
B. Begin oral feedings when alert.
If dysphagia with aspiration was an important
component of the symptoms preoperatively, consider
evaluating with a cookie swallow (OPMS)
before feeding.
C. Continue oral antibiotics for 5 to 7 days.
D. Voice rest
1. Absolute for 48 hours
2. Relative for 2 weeks: employ arms length
rule wherein the patient does not addess a person
unless they are within arms length.
E. Follow-up individualized based on symptoms
1. If dysphagia is a significant component,
consider cookie swallow postoperative day
1.
2. If voice is only concern, then follow up in 2
weeks; with videostroboscopic exam 6 weeks
postoperatively.
VII. CPT CODING
A. 31570, Laryngoscopy, direct, with injection
into vocal cord(s), therapeutic
B. 31570, Laryngoscopy, direct, with injection into
vocal cord(s), with operating microscope
VIII. SUGGESTED READING
A. Hoffman HT, Winters P, Sullivan MS. Gelfoam
injection for vocal cord paralysis prior to radiation
therapy. Ear Nose Throat J. 1991;70:385-386.
B. Lewy RB.Teflon injection: pointers and pitfalls.
Ann Otol Rhinol Laryngol. 1993;102:282-283.
C. Montgomery WW. Laryngeal paralysis: Teflon
injection. Ann Otol. 1979;8:647-657.
D. Olsen GT, Moreano EH, Arcuri MR, Hoffman HT. Dental
protection during rigid endoscopy. Laryngoscope.
1995;105:662-663.
E. Schramm VL, Lavorato AS.: Gelfoam paste injection
for vocal cord paralysis: temporary rehabilitation of
glottic incompetence. Laryngoscope.
1978;88.1268-1273.
|